Lakefront Biotherapeutics (LKFT) Cash & Equivalents (2013 - 2026)
Lakefront Biotherapeutics' Cash & Equivalents came in at $78.21 million for the quarter ended Mar 31, 2026, down 31.2% from $113.67 million a year earlier and down 23.5% from the prior quarter.
Powered by 
Analysis
Lakefront Biotherapeutics (LKFT) Cash & Equivalents (2013 - 2026) Analysis & Trends
As of Dec 31, 2025, Lakefront Biotherapeutics' Cash & Equivalents was $99.27 million, up 42.8% from the prior year.
- Cash & Equivalents carries a five-year compound annual growth rate of -47.3% (years ended Dec 2020 to Dec 2025).
- Going back by year, Cash & Equivalents was $69.53 million in the year ended Dec 31, 2024 (-87.3%), $546.7 million in the year ended Dec 31, 2023 (+2.1%), $535.53 million in the year ended Dec 31, 2022 (-79.7%) and $2.64 billion in the year ended Dec 31, 2021 (+8.4%).
- The five-year range for quarterly Cash & Equivalents is $60.98 million (the quarter ended Sep 30, 2024) to $3.18 billion (the quarter ended Jun 30, 2021).
- Year-over-year, Cash & Equivalents increased in three of the last six quarters, with an average decline of 11.1%.
- The fastest year-over-year change in Cash & Equivalents over five years came in the quarter ended Dec 31, 2025 (growth of 49.0%), and the weakest in the quarter ended Sep 30, 2024 (a decline of 89.0%).
- Business Quant data shows LKFT's Cash & Equivalents at $102.28 million (quarter ended Dec 31, 2025), $75.35 million (quarter ended Sep 30, 2025) and $81.13 million (quarter ended Jun 30, 2025) in the three quarters before the quarter ended Mar 31, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Lakefront Biotherapeutics | 1.90 Bn | 1.90 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 78.21 Mn |
| Dec 31, 2025 | 102.28 Mn |
| Sep 30, 2025 | 75.35 Mn |
| Jun 30, 2025 | 81.13 Mn |
| Mar 31, 2025 | 113.67 Mn |
| Dec 31, 2024 | 68.65 Mn |
| Sep 30, 2024 | 60.98 Mn |
| Mar 31, 2024 | 79.71 Mn |
| Dec 31, 2023 | 179.48 Mn |
| Sep 30, 2023 | 553.13 Mn |
| Mar 31, 2023 | 545.38 Mn |
| Dec 31, 2022 | 518.41 Mn |
| Sep 30, 2022 | 2.25 Bn |
| Mar 31, 2022 | 2.51 Bn |
| Dec 31, 2021 | 2.55 Bn |
| Jun 30, 2021 | 3.18 Bn |
| Mar 31, 2021 | 3.08 Bn |
| Dec 31, 2020 | 2.55 Bn |
| Jun 30, 2020 | 2.63 Bn |
| Mar 31, 2020 | 3.03 Bn |
API Access
Lakefront Biotherapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LKFT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "LKFT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LKFT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();